Dr. John Timmerman, MD
Claim this profileUCLA
Studies Cancer
Studies Follicular Lymphoma
4 reported clinical trials
6 drugs studied
Area of expertise
1Cancer
Stage II
Stage III
Stage IV
2Follicular Lymphoma
Stage II
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials John Timmerman, MD is currently running
Triple Drug Therapy
for Follicular Lymphoma
This phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma. Immunotherapy with obinutuzumab may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Ibrutinib and venetoclax may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving obinutuzumab, ibrutinib, and venetoclax together may work better in treating follicular lymphoma compared to each drug alone.
Recruiting1 award Phase 210 criteria
Anakinra
for Large B-Cell Lymphoma
This phase II trial studies how well anakinra works in preventing severe chimeric antigen receptor T-cell-related encephalopathy syndrome after chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma that has come back or has not responded to treatment. Immunosuppressive therapy, such as anakinra, is used to decrease the body?s immune response, which may prevent severe chimeric antigen receptor T-cell-related encephalopathy syndrome.
Recruiting1 award Phase 29 criteria
More about John Timmerman, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments John Timmerman, MD has experience with
- Anakinra
- IGN002
- Ibrutinib
- Obinutuzumab
- Venetoclax
- CRG-022
Breakdown of trials John Timmerman, MD has run
Cancer
Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Timmerman, MD specialize in?
John Timmerman, MD focuses on Cancer and Follicular Lymphoma. In particular, much of their work with Cancer has involved Stage II patients, or patients who are Stage III.
Is John Timmerman, MD currently recruiting for clinical trials?
Yes, John Timmerman, MD is currently recruiting for 2 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that John Timmerman, MD has studied deeply?
Yes, John Timmerman, MD has studied treatments such as Anakinra, IGN002, Ibrutinib.
What is the best way to schedule an appointment with John Timmerman, MD?
Apply for one of the trials that John Timmerman, MD is conducting.
What is the office address of John Timmerman, MD?
The office of John Timmerman, MD is located at: UCLA, Santa Monica, California 90404 United States. This is the address for their practice at the UCLA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.